Corbus Pharmaceuticals Holdings, Inc.

NasdaqCM:CRBP Stock Report

Market Cap: US$391.4m

Corbus Pharmaceuticals Holdings Balance Sheet Health

Financial Health criteria checks 2/6

Corbus Pharmaceuticals Holdings has a total shareholder equity of $-6.9M and total debt of $16.2M, which brings its debt-to-equity ratio to -234.8%. Its total assets and total liabilities are $28.3M and $35.2M respectively.

Key information

-234.8%

Debt to equity ratio

US$16.21m

Debt

Interest coverage ration/a
CashUS$20.91m
Equity-US$6.90m
Total liabilitiesUS$35.18m
Total assetsUS$28.27m

Recent financial health updates

Is Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Using Too Much Debt?

Nov 19
Is Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Using Too Much Debt?

Is Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Weighed On By Its Debt Load?

Feb 04
Is Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Weighed On By Its Debt Load?

Recent updates

Corbus: Ability To Have Best-In-Class Nectin-4 Targeting Drug

Jan 30

Corbus Pharmaceuticals GAAP EPS of -$0.11

Aug 09

Is Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Using Too Much Debt?

Nov 19
Is Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Using Too Much Debt?

Here's Why Shareholders Should Examine Corbus Pharmaceuticals Holdings, Inc.'s (NASDAQ:CRBP) CEO Compensation Package More Closely

Jun 12
Here's Why Shareholders Should Examine Corbus Pharmaceuticals Holdings, Inc.'s (NASDAQ:CRBP) CEO Compensation Package More Closely

Should Shareholders Reconsider Corbus Pharmaceuticals Holdings, Inc.'s (NASDAQ:CRBP) CEO Compensation Package?

May 14
Should Shareholders Reconsider Corbus Pharmaceuticals Holdings, Inc.'s (NASDAQ:CRBP) CEO Compensation Package?

What Kind Of Shareholders Hold The Majority In Corbus Pharmaceuticals Holdings, Inc.'s (NASDAQ:CRBP) Shares?

Mar 11
What Kind Of Shareholders Hold The Majority In Corbus Pharmaceuticals Holdings, Inc.'s (NASDAQ:CRBP) Shares?

Is Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Weighed On By Its Debt Load?

Feb 04
Is Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Weighed On By Its Debt Load?

Corbus Pharmaceuticals: Down But Not Out

Jan 29

Have Insiders Been Buying Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares This Year?

Jan 09
Have Insiders Been Buying Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares This Year?

Corbus's lenabasum shows benefit in autoimmune disorder

Nov 09

Financial Position Analysis

Short Term Liabilities: CRBP has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: CRBP has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: CRBP has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: CRBP's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CRBP has sufficient cash runway for 7 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: CRBP is forecast to have sufficient cash runway for 7 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.